Abstract
The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 Escherichia coli in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing E. coli may be underreported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 E. coli is of clinical relevance and should be monitored closely.
| Original language | English |
|---|---|
| Journal | Eurosurveillance |
| Volume | 25 |
| Issue number | 46 |
| ISSN | 1025-496X |
| DOIs | |
| Publication status | Published - 11.2020 |
Funding
| Funders | Funder number |
|---|---|
| UK Research and Innovation | 106157 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)
DFG Research Classification Scheme
- 2.21-03 Medical Microbiology and Mycology, Hygiene, Molecular Infection Biology
- 2.21-05 Immunology
Fingerprint
Dive into the research topics of 'Emergence of carbapenem-resistant ST131 escherichia coli carrying blaOXA-244 in germany, 2019 to 2020'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver